Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

被引：19
|
作者：
Wang, Xiaohui [1 ]
Li, Xiaolei [1 ]
Fu, Xiaoyu [2 ]
Bai, Miaomiao [1 ]
Li, Xiang [1 ]
Mei, Qian [1 ]
Nie, Jing [1 ]
Wu, Zhiqiang [1 ]
Han, Weidong [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Sch Life Sci, Inst Basic Med, Dept Mol Biol, Beijing 100853, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Obstet & Gynecol, Beijing 100853, Peoples R China
来源：
CURRENT PROTEIN & PEPTIDE SCIENCE | 2015年 / 16卷 / 04期
基金：
中国国家自然科学基金;
关键词：
OCSCs; ovarian cancer; chemoresistance; therapeutic target; MULLERIAN-INHIBITING SUBSTANCE; TUMOR-INITIATING CELLS; PULSED DENDRITIC CELLS; ACUTE MYELOID-LEUKEMIA; SIDE-POPULATION; ALDEHYDE DEHYDROGENASE; BREAST-CANCER; MALIGNANT GLIOMA; IMMUNE-RESPONSE; PROSTATE-CANCER;
D O I：
10.2174/138920371604150429151457
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Tumor recurrence followed by chemoresistance is a major cause of the poor survival rates for ovarian cancer. Despite advances in ovarian cancer chemotherapies and increased knowledge of the characteristics of ovarian cancer, chemoresistance is still an enormous clinical challenge. Current research suggests that ovarian cancer stem cells (OCSCs) might be involved in the occurrence of chemoresistance in ovarian cancer. In this review, we focus on the relationship of ovarian cancer stem cells with drug-resistant ovarian cancer phenotypes. We also discuss the current knowledge regarding ovarian cancer stem cell-based therapeutic strategies as attempts to overcome chemoresistance, the largest obstacle for successful treatment. Finally, we discuss methods for improving the treatment outcomes of ovarian cancer patients with chemoresistance.
引用
收藏
页码：270 / 278
页数：9
相关论文
共 50 条
  • [41] Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
    Danhua Ruan
    Jirui Wen
    Fei Fang
    Yuqin Lei
    Zhiwei Zhao
    Yali Miao
    Cell Death Discovery, 9
  • [42] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Liu, Yixuan
    Zhu, Keyu
    Guan, Xiaolin
    Xie, Suhong
    Wang, Yanchun
    Tong, Ying
    Guo, Lin
    Zheng, Hui
    Lu, Renquan
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [43] CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
    Feng, Xiaojie
    Bai, Xupeng
    Ni, Jie
    Wasinger, Valerie C.
    Beretov, Julia
    Zhu, Ying
    Graham, Peter
    Li, Yong
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [44] CRBP-1 Expression in Ovarian Cancer: A Potential Therapeutic Target
    Doldo, Elena
    Costanza, Gaetana
    Ferlosio, Amedeo
    Passeri, Daniela
    Bernardini, Sergio
    Scioli, Maria Giovanna
    Mazzaglia, Donatella
    Agostinelli, Sara
    Del Bufalo, Donatella
    Czernobilsky, Bernard
    Orlandi, Augusto
    ANTICANCER RESEARCH, 2014, 34 (07) : 3303 - 3312
  • [45] Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
    Linah Al-Alem
    Jillian M. Prendergast
    Justin Clark
    Bianca Zarrella
    Dominique T. Zarrella
    Sarah J. Hill
    Whitfield B. Growdon
    Venkatesh Pooladanda
    David R. Spriggs
    Daniel Cramer
    Kevin M. Elias
    Rawan I. Nazer
    Steven J. Skates
    Jeff Behrens
    Daniel T. Dransfield
    Bo R. Rueda
    Journal of Ovarian Research, 17
  • [46] STAT3 signaling in ovarian cancer: a potential therapeutic target
    Liang, Renba
    Chen, Xishan
    Chen, Li
    Wan, Fangzhu
    Chen, Kaihua
    Sun, Yongchu
    Zhu, Xiaodong
    JOURNAL OF CANCER, 2020, 11 (04): : 837 - 848
  • [47] Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
    Al-Alem, Linah
    Prendergast, Jillian M.
    Clark, Justin
    Zarrella, Bianca
    Zarrella, Dominique T.
    Hill, Sarah J.
    Growdon, Whitfield B.
    Pooladanda, Venkatesh
    Spriggs, David R.
    Cramer, Daniel
    Elias, Kevin M.
    Nazer, Rawan I.
    Skates, Steven J.
    Behrens, Jeff
    Dransfield, Daniel T.
    Rueda, Bo R.
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [48] Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
    Lee, Jeong-Won
    Ryu, Ji-Yoon
    Yoon, Gun
    Jeon, Hye-Kyung
    Cho, Young-Jae
    Choi, Jung-Joo
    Song, Sang Yong
    Do, In-Gu
    Lee, Yoo-Young
    Kim, Tae-Joong
    Choi, Chel Hun
    Kim, Byoung-Gie
    Bae, Duk-Soo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 221 - 229
  • [49] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Yixuan Liu
    Keyu Zhu
    Xiaolin Guan
    Suhong Xie
    Yanchun Wang
    Ying Tong
    Lin Guo
    Hui Zheng
    Renquan Lu
    Journal of Ovarian Research, 14
  • [50] Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
    Nakamura, Koji
    Sawada, Kenjiro
    Kobayashi, Masaki
    Miyamoto, Mayuko
    Shimizu, Aasa
    Yamamoto, Misa
    Kinose, Yasuto
    Kimura, Tadashi
    CANCERS, 2019, 11 (08)
12345